Noticias de ABVC_US

Noticias del mercado

Últimas noticias sobre ABVC_US — 76 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ABVC_US ✕ 76 resultados
15/06/2026 ABVC_US — newsline.com
ABVC BioPharma Inc. (ABVC) Surges 7.39% — Testing Key Resistance at $1.34 - Relative Volume
10/06/2026 ABVC_US — newsline.com
ABVC BioPharma Inc. (ABVC) Edges Higher as Shares Test Resistance Near $1.41 - Ichimoku Kumo Break
10/06/2026 ABVC_US — newsline.com
ABVC BioPharma Inc. (ABVC) Edges Higher as Shares Test Resistance Near $1.41 - Rating Change
08/06/2026 ABVC_US — newsline.com
ABVC BioPharma Inc. (ABVC) Q1 2025 Earnings: Narrowing Losses Amid Clinical Progress - Revenue Recognition Risk
08/06/2026 ABVC_US — newsline.com
ABVC BioPharma Inc. (ABVC) Q1 2025 Earnings: Narrowing Losses Amid Clinical Progress - Pre-Announcement Alert
05/06/2026 ABVC_US — newsline.com
ABVC BioPharma Slips 7.6%: Support at $1.26 in Focus After Volatile Session - Seasonality Effect
05/06/2026 ABVC_US — newsline.com ES ← EN
ABVC BioPharma cae un 7,6%: soporte de 1,26 dólares en foco después de una sesión volátil - Señal FRAMA

ABVC BioPharma Slips 7.6%: Support at $1.26 in Focus After Volatile Session - FRAMA Signal

04/06/2026 ABVC_US — Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
04/06/2026 ABVC_US — newsline.com
ABVC BioPharma Surges 6.64%: Shares Break Above Key Support as Momentum Builds - Extension Target
04/06/2026 ABVC_US — newsline.com
ABVC BioPharma Surges 6.64%: Shares Break Above Key Support as Momentum Builds - Up Down Volume
03/06/2026 ABVC_US — Intellectia AI
ABVC PE Ratio & Valuation, Is ABVC Overvalued
30/05/2026 ABVC_US — The Legal Advocate
ABVC BioPharma Inc. (ABVC) Q1 2025 Earnings: Modest Loss Reported Amid Ongoing Clinical Development
30/05/2026 ABVC_US — The Legal Advocate
ABVC BioPharma Inc. (ABVC) Q1 2025 Earnings: Modest Loss Reported Amid Ongoing Clinical Development - Margin Improvement Report
28/05/2026 ABVC_US — The Legal Advocate ES ← EN
ABVC BioPharma sube, probando la resistencia en 1,48 dólares - Índice de porcentaje alcista

Fuente confiable de informes legales y noticias de última hora sobre justicia, seguridad y derechos humanos en todo Estados Unidos.

28/05/2026 ABVC_US — The Legal Advocate
ABVC BioPharma Consolidates at $1.39 as Support and Resistance Levels Narrow - PCR Divergence

Fuente confiable de informes legales y noticias de última hora sobre justicia, seguridad y derechos humanos en todo Estados Unidos.

28/05/2026 ABVC_US — The Legal Advocate
ABVC BioPharma Consolidates at $1.39 as Support and Resistance Levels Narrow - Factor Rotation
28/05/2026 ABVC_US — thelegaladvocate.com ES ← EN
ABVC BioPharma se consolida en $1,39 mientras los niveles de soporte y resistencia se estrechan - Golden Cross

ABVC BioPharma Consolidates at $1.39 as Support and Resistance Levels Narrow - Golden Cross

28/05/2026 ABVC_US — newsline.com
ABVC BioPharma Consolidates at $1.39 as Support and Resistance Levels Narrow - Sentiment Extreme
28/05/2026 ABVC_US — newsline.com
ABVC BioPharma Consolidates at $1.39 as Support and Resistance Levels Narrow - ETF Outflow Streak
28/05/2026 ABVC_US — newsline.com
ABVC BioPharma Creeps Higher, Testing Resistance at $1.48 - Extension Target

Página 1 de 4

keyboard_arrow_up